1. Homepage
  2. Equities
  3. Saudi Arabia
  4. Saudi Arabian Stock Exchange
  5. Middle East Healthcare Company
  6. News
  7. Summary
    4009   SA141H01UKH9

MIDDLE EAST HEALTHCARE COMPANY

(4009)
  Report
End-of-day quote Saudi Arabian Stock Exchange  -  2022-08-17
33.65 SAR   -0.15%
08/15Middle East Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
07/06Middle East Healthcare Company Announces Approval of Awarding of Contracts for the Construction of Medical Tower and Inpatient beds expansion in SGH Jeddah to IHCC (Related Party)
CI
06/26Middle East Healthcare Company (Saudi German Health) Announces the Opening of the Saudi German Clinics Complex in the Al Samer District in the City of Abha
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Marubeni - Middle East healthcare industry continues to attract international investors

06/10/2022 | 08:43am EDT

The fast-growing Middle East healthcare industry, driven by the increase of healthcare related expenditures from both the public and private sectors, fuels the interest of international companies looking to invest in this growing sector in Middle East in general and the UAE in particular.

Marubeni Corporation (hereinafter, 'Marubeni') and Lunatus Marketing & Consulting FZCO (hereinafter, 'Lunatus') have announced that Marubeni invested and acquired shares in Dubai Based Lunatus.

Lunatus, one of the largest and fastest growing pharmaceutical companies in the MENA region, is a market-leading turnkey solutions provider that handles regulatory, marketing, sales, distribution, and supply chain management for international pharmaceutical & medical device companies. Marubeni, a leading Japanese integrated trading and investment business conglomerate, has its healthcare & medical industry business network in China(1) , ASEAN(2) etc. with the intention to expand the network globally, Marubeni identifies the growth potential in pharmaceutical-related business and medical service businesses in Middle East.

Through the broad regional Lunatus network, Marubeni will bridge the Japan-Middle East markets and will bring Japanese high-quality pharmaceuticals and medical devices to Middle East to accommodate the increasing demand in the region. Moreover, by leveraging their joint expertise, Marubeni and Lunatus intend to explore expanding the business across the other emerging markets including ASEAN and Africa.

Mr. Eisuke Kamide, General Manager of Marubeni's Healthcare & Medical Business Department, commented: 'We are proud to form a strategic alliance partnership with Lunatus, and will continue exploring opportunities in the Middle East pharmaceutical market. Marubeni is focused on the MENA market which has a large growth potential, and this transaction will enable us to expand our pharmaceutical and medical device business network from China to the Middle East and Africa. Through these efforts, we would like to reduce the healthcare disparity globally and regionally, bringing value to all patients, families and stakeholders.

Dr. Lina Kouatly, Founder and Chief Executive Officer of Lunatus commented: 'Over the last 19 years, we have built one of the largest regional pharmaceutical companies spanning the GCC and Levant regions. We are thrilled to partner with Marubeni in further consolidating and expanding our footprint as we explore unique growth opportunities regionally and into the Asian markets. This transaction presents a unique strategic opportunity to partner alongside Marubeni, a global conglomerate, in further growing the Lunatus brand.'

(C) 2022 Electronic News Publishing, source ENP Newswire

Stocks mentioned in the article
ChangeLast1st jan.
MARUBENI CORPORATION 2.02% 1391.5 Delayed Quote.21.84%
MIDDLE EAST HEALTHCARE COMPANY -0.15% 33.65 End-of-day quote.6.32%
All news about MIDDLE EAST HEALTHCARE COMPANY
08/15Middle East Healthcare Company Reports Earnings Results for the Second Quarter and Six ..
CI
07/06Middle East Healthcare Company Announces Approval of Awarding of Contracts for the Cons..
CI
06/26Middle East Healthcare Company (Saudi German Health) Announces the Opening of the Saudi..
CI
06/10Marubeni - Middle East healthcare industry continues to attract international investors
AQ
05/15Middle East Healthcare Company Reports Earnings Results for the First Quarter Ended Mar..
CI
03/31Middle East Healthcare Company Reports Earnings Results for the Full Year Ended Decembe..
CI
2021Middle East Healthcare Company Reports Earnings Results for the Third Quarter Ended Sep..
CI
2021Middle East Healthcare Company Reports Earnings Results for the Second Quarter Ended Ju..
CI
2021Middle East Healthcare Company Reports Earnings Results for the First Quarter Ended Mar..
CI
2021MIDDLE EAST HEALTHCARE : Imprivata and Emerging Global Technologies partner to bring innov..
AQ
More news
Financials
Sales 2022 2 157 M 574 M 574 M
Net income 2022 77,0 M 20,5 M 20,5 M
Net Debt 2022 2 138 M 569 M 569 M
P/E ratio 2022 40,3x
Yield 2022 -
Capitalization 3 097 M 825 M 825 M
EV / Sales 2022 2,43x
EV / Sales 2023 2,16x
Nbr of Employees 4 220
Free-Float 40,2%
Chart MIDDLE EAST HEALTHCARE COMPANY
Duration : Period :
Middle East Healthcare Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MIDDLE EAST HEALTHCARE COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 4
Last Close Price 33,65 SAR
Average target price 30,06 SAR
Spread / Average Target -10,7%
EPS Revisions
Managers and Directors